Harvard Bioscience
HBIO
#8485
Rank
S$0.15 B
Marketcap
$3.50
Share price
-1.10%
Change (1 day)
-40.35%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of June 2024 : S$5.27 M

According to Harvard Bioscience's latest financial reports the company has S$5.27 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$5.65 M-6.4%
2022-12-31S$6.04 M-42.7%
2021-12-31S$10.54 M-4.07%
2020-12-31S$10.99 M-1.9%
2019-12-31S$11.2 M0.67%
2018-12-31S$11.13 M60.33%
2017-12-31S$6.94 M-14.26%
2016-12-31S$8.09 M-15.18%
2015-12-31S$9.54 M-48.87%
2014-12-31S$18.67 M-42.81%
2013-12-31S$32.65 M29.04%
2012-12-31S$25.3 M9.07%
2011-12-31S$23.2 M-8.63%
2010-12-31S$25.39 M8.93%
2009-12-31S$23.31 M18.34%
2008-12-31S$19.69 M-23.85%
2007-12-31S$25.86 M80.27%
2006-12-31S$14.34 M12.91%
2005-12-31S$12.7 M-37.85%
2004-12-31S$20.44 M46.11%
2003-12-31S$13.99 M-47.33%
2002-12-31S$26.57 M-51.16%
2001-12-31S$54.39 M-12.37%
2000-12-31S$62.07 M1456.02%
1999-12-31S$3.98 M152.49%
1998-12-31S$1.58 M